Article metrics

Download PDFPDF
THU0143 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analyses of efficacy endpoints by subgroups in a pooled phase 2 and 3 rheumatoid arthritis study population

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014400
Mar 20141200
Apr 2014501
May 2014100
Jun 2014200
Jul 2014200
Aug 2014100
Sep 2014701
Oct 2014300
Nov 2014400
Dec 2014600
Feb 2015500
Mar 2015200
Apr 2015300
May 2015100
Jun 2015200
Jul 2015300
Aug 2015900
Sep 2015700
Oct 2015801
Nov 2015702
Dec 2015500
Jan 2016500
Feb 2016300
Mar 20161401
Apr 2016100
May 2016601
Jun 20161904
Jul 2016300
Aug 2016400
Sep 2016600
Oct 20161709
Nov 2016601
Dec 2016800
Jan 20171003
Feb 2017400
Mar 20171101
Apr 2017701
May 2017801
Jun 20171000
Jul 20171702
Aug 20172401
Sep 2017802
Oct 2017400
Nov 2017600
Dec 20172407
Jan 20181405
Feb 2018200
Mar 20181602
Apr 20182401
May 20182201
Jun 2018200
Jul 20181000
Aug 2018600
Sep 20182003
Oct 20181603
Nov 2018800
Dec 2018200
Feb 20191601
Mar 2019200
Apr 2019200
May 2019600
Jun 20191401
Jul 20191300
Aug 20191001
Sep 2019300
Oct 2019600
Nov 2019200
Dec 2019200
Jan 2020400
Feb 2020500
Mar 2020200
May 20201200
Jun 20201101
Jul 20201100
Aug 2020200
Sep 20201201
Oct 2020700
Nov 20201701
Dec 2020400
Jan 20211001
Feb 2021401
Apr 2021600
May 2021500
Jun 2021500
Oct 2021800
Nov 20211701
Dec 2021400
Jan 20221000
Feb 2022900
Mar 2022400
Apr 20221200
May 2022600
Jun 2022200
Jul 20221800
Aug 20221800
Sep 20222800
Oct 20222200
Nov 20221600
Dec 20221400
Jan 20231200
Feb 2023400
Mar 20235400
May 2023600
Jun 2023300
Jul 2023700
Aug 20232000
Sep 2023800
Nov 2023800
Dec 2023600
Jan 2024400
Feb 2024600
Mar 2024400
Total989063